How to Help Your Patients Save Money on Juluca: A Provider's Guide to Savings Programs

At a retail price of approximately $5,000 per month, Juluca (dolutegravir/rilpivirine) is out of reach without financial assistance for the vast majority of patients — even those with insurance. Cost-related non-adherence is one of the most preventable causes of virologic failure, and proactively connecting patients with savings programs at the time of prescribing is a clinical imperative, not just an administrative nicety.

This guide walks through every major savings program available for Juluca in 2026, with practical guidance on eligibility, how to enroll, and how to integrate these programs into your practice workflow.

Understanding the Juluca Cost Landscape for Your Patients

Your patients are likely in one of these situations:

Commercially insured — typically placed on Tier 3-5 specialty formulary; copays of $100-$500+/month before any manufacturer assistance. ViiV Connect Savings Card is the primary tool.

Medicare Part D — Juluca is Tier 5 (specialty); high cost-sharing. Cannot use manufacturer copay cards. Medicare Extra Help (LIS) and ADAP are key resources.

Medicaid — Juluca is covered in most state Medicaid programs, often with low or no copays. Prior authorization and step therapy may apply.

Uninsured or underinsured — ViiV Healthcare PAP and ADAP are the primary resources. With the right programs, these patients can receive Juluca at no cost.

Program 1: ViiV Connect Savings Card (Commercially Insured Patients)

The ViiV Connect Savings Card is your most powerful tool for commercially insured patients. Enroll patients at the time of prescribing — don't wait for them to encounter the sticker shock at the pharmacy.

Key details for providers:

Benefit: Reduces patient cost to as little as $0/month; maximum $6,250/year savings

Eligibility: Commercial insurance required; excludes Medicare, Medicaid, and other government-funded programs

Enrollment: viivconnect.com or call 1-844-588-3288; enrollment takes minutes and can be done in-office or by the patient at home

No income requirement for the savings card; eligibility is based on insurance type

Best practice: print a card or save the digital card before the patient's first fill

Program 2: ViiV Healthcare Patient Assistance Program (Uninsured Patients)

For patients who are uninsured or underinsured, the ViiV Healthcare Patient Assistance Program (PAP) can provide Juluca at no cost. This is a manufacturer-sponsored program, separate from ADAP, with its own eligibility criteria.

Provider steps to enroll a patient:

Patient completes the PAP application at viivconnect.com or by calling 1-844-588-3288.

Provider signs the application (co-signature required).

Submit by mail or fax as directed on the application.

Eligible patients typically receive medication within 2-3 weeks of approval.

Most patients without insurance and with limited incomes qualify. The income threshold is typically based on federal poverty level guidelines. Contact ViiV Connect for current eligibility details.

Program 3: ADAP — AIDS Drug Assistance Program

ADAP (AIDS Drug Assistance Program) is a critical federal safety net for people living with HIV. Funded under the Ryan White HIV/AIDS Program and administered by states, ADAP provides HIV medications — including Juluca — at no cost to eligible individuals.

Eligibility varies by state but generally requires:

Confirmed HIV diagnosis

U.S. residence

Income at or below a state-defined threshold (commonly 200-500% of FPL)

Uninsured or underinsured (some states extend to insured patients)

As a provider, you play a key role in ADAP enrollment. Referral forms require your signature and documentation of the patient's HIV status and current medication needs. Consider designating a case manager or social worker in your practice to support ADAP applications for eligible patients.

Program 4: Medicare Extra Help (Low Income Subsidy)

For Medicare patients with limited income and resources, the Extra Help program (also called the Low Income Subsidy, or LIS) can significantly reduce Part D cost-sharing. Patients who qualify may pay as little as $0-$10 per month for Juluca instead of full specialty tier cost-sharing.

Eligibility is based on income and resources. Refer patients to:

Social Security Administration (1-800-772-1213) to apply

State Health Insurance Assistance Program (SHIP) — free counseling on Medicare benefits

Many states also have ADAP programs that supplement Medicare coverage for HIV medications

Navigating Formulary Appeals and Step Therapy Exemptions

When an insurer denies coverage or places Juluca on a high-cost tier, formulary appeals and step therapy exemption requests can be effective tools:

Document clinical rationale: Include viral load history, prior ART regimen, resistance testing results, and specific clinical reason for Juluca (e.g., NRTI-sparing for renal protection).

Request a peer-to-peer review: Many insurers offer this option, where you speak directly with the plan's medical director. These calls are often faster and more effective than written appeals.

Step therapy exemptions: If a payer requires trying a different regimen before Juluca, document why alternatives are clinically inappropriate (prior failure, resistance, tolerability) for the exemption request.

Building a Practice-Level Workflow for Juluca Savings Programs

The most efficient approach is to build savings program enrollment into your prescribing workflow:

At prescribing: Identify insurance type. Enroll commercially insured patients in ViiV Connect immediately. Uninsured patients: start PAP or ADAP paperwork same day.

At first follow-up: Confirm patient received medication and knows their out-of-pocket cost. Troubleshoot any access issues.

Annually: Reassess insurance coverage. ViiV Connect cards and ADAP eligibility may need renewal. Re-enroll as needed.

For patients who have their costs covered but still struggle to find Juluca at a pharmacy, medfinder for providers can help locate available pharmacies near your patients. For a broader clinical guide to Juluca access, see Juluca: what providers need to know in 2026.